Revance Therapeutics shares owned by Accredited Investors
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Accredited Investors
from 13F filings
Historical chart of Accredited Investors investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Accredited Investors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Accredited Investors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $67k | 13k | 5.19 |
| 2024-03-31 | $63k | 13k | 4.92 |
| 2023-12-31 | $113k | 13k | 8.79 |
| 2023-09-30 | $147k | 13k | 11.47 |
| 2023-06-30 | $325k | 13k | 25.31 |
| 2023-03-31 | $660k | 21k | 32.21 |
| 2022-12-31 | $378k | 21k | 18.46 |
| 2022-09-30 | $553k | 21k | 26.99 |
| 2022-06-30 | $283k | 21k | 13.81 |
| 2022-03-31 | $400k | 21k | 19.52 |
| 2021-12-31 | $334k | 21k | 16.30 |
| 2021-09-30 | $571k | 21k | 27.87 |
| 2021-06-30 | $607k | 21k | 29.62 |
| 2021-03-31 | $573k | 21k | 27.96 |
| 2020-12-31 | $581k | 21k | 28.35 |